Kyntra Bio (KYNB) Interest Coverage Ratio (2014 - 2026)
Kyntra Bio (KYNB) posted Interest Coverage Ratio of 4.61 for Q1 2026, up 98.98% sequentially from 450.4 in Q4 2025, and up 7.39% YoY from 4.29 in Q1 2025.
Kyntra Bio (KYNB) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Kyntra Bio has reported Interest Coverage Ratio for 13 years, with the latest figure at 4.61 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 7.39% year-over-year to 4.61 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.52 (up 9.79% YoY) and the FY2025 annual result came in at 5.24, up 43.54% from the prior year.
- Interest Coverage Ratio improved to 4.61 in Q1 2026 per KYNB's latest filing, from 450.4 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.7 in Q4 2024 and troughed at 450.4 in Q4 2025.
- A 5-year average of 40.62 and a median of 16.96 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio soared 99.65% in 2022, then slumped 64167.09% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 4.36 in 2022, then tumbled by 506.88% to 26.45 in 2023, then jumped by 97.35% to 0.7 in 2024, then plunged by 64167.09% to 450.4 in 2025, then soared by 98.98% to 4.61 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 4.61, 450.4, and 2.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn | - |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 1.42 |
| 10 | Kyntra Bio | 29.67 Mn | 29.67 Mn | 1.47 Mn | -7.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.42 |
| Mar 31, 2026 | -4.61 |
| Dec 31, 2025 | -450.40 |
| Sep 30, 2025 | -2.60 |
| Jun 30, 2025 | -4.02 |
| Mar 31, 2025 | -4.97 |
| Dec 31, 2024 | -0.70 |
| Sep 30, 2024 | -16.45 |
| Jun 30, 2024 | -16.00 |
| Mar 31, 2024 | -16.96 |
| Dec 31, 2023 | -26.45 |
| Sep 30, 2023 | -21.89 |
| Jun 30, 2023 | -28.69 |
| Mar 31, 2023 | -32.08 |
| Dec 31, 2022 | -4.36 |
| Sep 30, 2022 | -23.09 |
| Jun 30, 2022 | -19.19 |
| Mar 31, 2022 | -18.04 |
| Dec 31, 2021 | -1,229.46 |
| Sep 30, 2021 | 0.42 |